BUPRENORPHINE JUNO; BUPRENORPHINE JN; BUPRESPAN; BUPRENORPHINE DB (Juno Pharmaceuticals Pty Ltd)
Product name
BUPRENORPHINE JUNO; BUPRENORPHINE JN; BUPRESPAN; BUPRENORPHINE DB
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
210 (255 working days)
Active ingredients
buprenorphine
Registration type
New generic medicine
Indication
BUPRENORPHINE JUNO; BUPRENORPHINE JN; BUPRESPAN; BUPRENORPHINE DB (transdermal drug delivery system) is indicated for the management of moderate to severe pain